In vivo distribution of integrins in renal cell carcinoma : integrin-phenotype alteration in different degrees of tumor differentiation and VLA-2 involvement in tumor metastasisANASTASSIOU, G; ANASTASSIOU, G; ANASTASSIOU, G; ANASTASSIOU, G; DUENSING, S et al.Cancer biotherapy. 1995, Vol 10, Num 4, pp 287-292, issn 1062-8401Article

Interferon α-2a and external beam radiotherapy in the initial management of patients with glioma : a pilot study of the national biotherapy study groupDILLMAN, R. O; WIEMANN, M; OLDHAM, R. K et al.Cancer biotherapy. 1995, Vol 10, Num 4, pp 265-271, issn 1062-8401Article

Correlation between malignancy level of AKR lymphoma variants and sensitivity to hyperthermiaLEIBOVICI, J; KLORIN, G; KLEIN, O et al.Cancer biotherapy. 1995, Vol 10, Num 1, pp 53-60, issn 1062-8401Conference Paper

Subcutaneous interleukin-2 and alpha-interferon in advanced colorectal carcinoma: a phase II studyHJELM, A.-L; RAGNHAMMAR, P; FAGERBERG, J et al.Cancer biotherapy. 1995, Vol 10, Num 1, pp 5-12, issn 1062-8401Conference Paper

The integration of high-dose chemotherapy and biotherapy: initial 5-year experience with autologous bone marrow transplantation in a comprehensive community cancer centDILLMAN, R. O; BARTH, N. M; MAHDAVI, K et al.Cancer biotherapy. 1995, Vol 10, Num 1, pp 25-36, issn 1062-8401Conference Paper

The clinical experience with interleukin-2 in cancer therapyDILLMAN, R. O.Cancer biotherapy. 1994, Vol 9, Num 3, pp 183-209, issn 1062-8401Article

Enhancement of anti-cancer activity of cisdiaminedichloroplatinum by the protein-bound polysaccharide of Coriolus Versicolor QUEL (PS-K) in vitroKOBAYASHI, Y; KARIYA, K; SAIGENJI, K et al.Cancer biotherapy. 1994, Vol 9, Num 4, pp 351-358, issn 1062-8401Article

Immunotherapy with low-dose interleukin-2 and anti-transforming growth factor-β antibody in a murine tumor modelXIAO WEN MAO; KETTERING, J. D; GRIDLEY, D. S et al.Cancer biotherapy. 1994, Vol 9, Num 4, pp 317-327, issn 1062-8401Article

In vitro effects of pentoxifylline and doxorubicin on cell survival and DNA damage in sensitive and MDR-P388 leukemia cellsARUNDHATI VILADKAR; MANIK CHITNIS.Cancer biotherapy. 1994, Vol 9, Num 2, pp 143-151, issn 1062-8401Article

Dual effects of cytokines in regulation of MHC-unrestricted cell mediated cytotoxicityREITER, Z; RAPPAPORT, B.Critical reviews in immunology. 1993, Vol 13, Num 1, pp 1-34, issn 1040-8401Article

Effects of anti-transforming growth factor-β antibody and interleukin-2 in tumor-bearing miceGRIDLEY, D. S; SURA, S. S; UHM, J.-R et al.Cancer biotherapy. 1993, Vol 8, Num 2, pp 159-170, issn 1062-8401Article

Evaluation of a new test for colorectal neoplasms: a prospective study of asymptomatic populationSAKAMOTO, K; MURATANI, M; OGAWA, T et al.Cancer biotherapy. 1993, Vol 8, Num 1, pp 49-55, issn 1062-8401Article

Muramyl peptides augment the in vitro and in vivo cytostatic activity of canine plastic-adherent mononuclear cells against canine osteosarcoma cellsSMITH, B. W; KURZMAN, I. D; SCHULTZ, K. T et al.Cancer biotherapy. 1993, Vol 8, Num 2, pp 137-144, issn 1062-8401Article

Penetration and binding of epidermal growth factor-dextran conjugates in spheroids of human glioma originLINDSTRÖM, A; CARLSSON, J.Cancer biotherapy. 1993, Vol 8, Num 2, pp 145-158, issn 1062-8401Article

Evolution of immune reactionsSIMA, P; VETVICKA, V.Critical reviews in immunology. 1993, Vol 13, Num 2, pp 83-114, issn 1040-8401Article

Limited efficacy of interferon-α and vinblastine as second line biochemotherapy regimen in patients with progressive metastatic renal cell carcinomaLOPEZ HANNINEN, E; FENNER, M; KIRCHNER, H et al.Cancer biotherapy. 1993, Vol 8, Num 4, pp 301-306, issn 1062-8401Article

Successful in vivo generation of canine lymphokine-activated killer cells by continuous recombinant interleukin-2 infusion through the splenic arteryOHNISHI, H; OKUNO, K; YASUTOMI, M et al.Cancer biotherapy. 1993, Vol 8, Num 3, pp 213-222, issn 1062-8401Article

The impact of interleukin-2 on survival in renal cancer: a multivariate analysisJONES, M; PHILIP, T; PALMER, P et al.Cancer biotherapy. 1993, Vol 8, Num 4, pp 275-288, issn 1062-8401Article

recombinant bifunctional molecule FV/IFN-γ possesses the anti-tumor FV as well as the gamma interferon activitiesJIM XIANG; YIMIN QI; XIMIN LUO et al.Cancer biotherapy. 1993, Vol 8, Num 4, pp 327-337, issn 1062-8401Article

T-cell receptors : germline polymorphism and patterns of usage in demyelinating diseasesUUKU, K; JOSHI, N; HAUSER, S. L et al.Critical reviews in immunology. 1992, Vol 11, Num 6, pp 381-393, issn 1040-8401Article

Controversies in reproductive immunologyCLARK, D. A.Critical reviews in immunology. 1991, Vol 11, Num 3-4, pp 215-247, issn 1040-8401Article

Molecular biology of murine MHC class II genesLAFUSE, W. P.Critical reviews in immunology. 1991, Vol 11, Num 3-4, pp 167-194, issn 1040-8401Article

Cancer clinical trials in the community setting: a 20 year retrospectiveAVENT, R. A; DILLMAN, R. O.Cancer biotherapy. 1995, Vol 10, Num 2, pp 95-113, issn 1062-8401Article

Combination therapy with traditional Chinese medicines and Streptococcus pyogenes products (OK 432) for endogenous tumor necrosis factor therapy. A preliminary reportHARANAKA, K; SAKURAI, A; SATOMI, N et al.Cancer biotherapy. 1995, Vol 10, Num 2, pp 131-138, issn 1062-8401Article

In vitro cell-mediated immune responses induced by a polyvalent allogeneic melanoma vaccineADLER, A; ORAZ, R; BYSTRYN, J.-C et al.Cancer biotherapy. 1995, Vol 10, Num 3, pp 211-224, issn 1062-8401Article